Complex I and energy thresholds in the brain

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1777, Issue 7-8, 2008, Pages 777-782

  Pathak, Rashmi U ^a   Davey, Gavin P ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Brain mitochondria; Complex I; Metabolic control analysis; Neurodegeneration; Parkinson's disease

Indexed keywords

CYTOCHROME C OXIDASE; GLUTATHIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE;

BRAIN MITOCHONDRION; COMPLEX FORMATION; COMPLEX I DEFICIENCY; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REVIEW;

BRAIN; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX III; ENERGY METABOLISM; GLUTATHIONE; HUMANS; MITOCHONDRIA; PARKINSON DISEASE;

PARKINSONIA;

EID: 50949104833     PISSN: 00052728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbabio.2008.05.443     Document Type: Review

References (84)

1. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 31 2 (1992) 119-130
2. Ames B.N., Shigenaga M.K., and Hagen T.M. Mitochondrial decay in aging. Biochim. Biophys. Acta 1271 (1995) 165-170
3. Hornykiewicz O. Parkinson's disease: from brain homogenate to treatment. Fed. Proc. 32 (1973) 183-190
4. Calne D.B., and Langston J.W. Aetiology of Parkinson's disease. Lancet 8365 (1983) 1457-1459
5. Schapira A.H., Cooper J.M., Dexter D., Jenner P., Clark J.B., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1 (1989) 1269
6. Schapira A.H., Cooper J.M., Dexter D., Jenner P., Clark J.B., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
7. Schapira A.H., Mann V.M., Cooper J.M., Dexter D., Daniel S.E., Jenner P., Clark J.B., and Marsden C.D. Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55 (1990) 2142-2145
8. Parker Jr. W.D., and Parks J.K. Mitochondrial ND5 mutations in idiopathic Parkinson's disease. Biochem. Biophys. Res. Commun. 326 (2005) 667-669
9. Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26 (2006) 5256-5264
10. Parker Jr. W.D., Parks J.K., and Swerdlow R.H. Complex I deficiency in Parkinson's disease frontal cortex. Brain Res. 1189 (2008) 215-218
11. Greenamyre J.T., Sherer T.B., Betarbet R., and Panov A.V. Complex I and Parkinson's disease. IUBMB Life. 52 (2001) 135-141
12. Dawson T.M., and Dawson V.L. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302 (2003) 819-822
13. Tretter L., Sipos I., and Adam-Vizi V. Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease. Neurochem. Res. (2004) 569-577
14. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., and Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 14 (2008) 504-506
15. Kilbride S.M., Telford J.E., Tipton K.F., and Davey G.P. Partial inhibition of complex I activity increases Ca(2+)-independent glutamate release rates from depolarized synaptosomes. J. Neurochem. (2008) (Electronic publication ahead of print)
16. Davey G.P., Canevari L., and Clark J.B. Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions. J. Neurochem. 69 (1997) 2564-2570
17. Davey G.P., and Clark J.B. Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria. J. Neurochem. 66 (1996) 1617 24
18. Davey G.P., Peuchen S., and Clark J.B. Energy thresholds in brain mitochondria: potential involvement in neurodegeneration. J. Biol. Chem. 273 (1998) 12753-12757
19. Groen A.K., Wanders R.J.A., Westerhoff H.V., van der Meer R., and Tager J.M. Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257 (1982) 2754-2757
20. Moreno-Sanchez R., Devars S., Lopez-Gomez F., Uribe A., and Corona N. Distribution of control of oxidative phosphorylation in mitochondria oxidizing NAD-linked substrates. Biochim. Biophys. Acta 1060 (1991) 284-292
21. Inomoto T., Tanaka A., Mori S., Jin M.B., Sato B., Yanabu N., Tokuku A., Kitai T., Ozawa K., and Yamaoka Y. Changes in the distribution of the control of the mitochondrial oxidative phosphorylation in regenerating rabbit liver. Biochim. Biophys. Acta 1188 (1994) 311-317
22. Korzeniewski B., and Mazat J.P. Factors determining the oxygen consumption rate (VO2) on-kinetics in skeletal muscles. Biochem. J. 319 (1996) 143-148
23. Cocco T., Pacelli C., Sgobbo P., and Villani G. Control of OXPHOS efficiency by complex I in brain mitochondria. Neurobiol. Aging. (2008) (Electronic publication ahead of print)
24. Kacser H., and Burns J.A. Rate Control of Biological Processes (1973), Cambridge University Press, Cambridge, UK 65-104
25. Tager J.M., Wanders R.J.A., Groen A.K., Kunz W., Bohnensack R., Kuster U., Letko G., Bohme G., Duszynski J., and Wojtczak L. Control of mitochondrial respiration. FEBS Lett. 151 (1983) 1-9
26. 2+ concentrations. J. Biol. Chem. 260 (1985) 4028-4034
27. Gellerich F.N., Bohnensack R., and Kunz W. Control of mitochondrial respiration. The contribution of the adenine nucleotide translocator depends on the ATP- and ADP-consuming enzymes. Biochim. Biophys. Acta 722 (1983) 381-391
28. Brand M.D., Hafner R.P., and Brown G.C. Control of respiration in non-phosphorylating mitochondria is shared between the proton leak and the respiratory chain. Biochem. J. 255 (1988) 535-539
29. Joyce O.J., Farmer M.K., Tipton K.F., and Porter R.K. Oxidative phosphorylation by in situ synaptosomal mitochondria from whole brain of young and old rats. J. Neurochem. 86 (2003) 1032-1041
30. Rossignol R., Faustin B., Rocher C., Malgat M., Mazat J.P., and Letellier T. Mitochondrial threshold effects. Biochem. J. 370 (2003) 751-762
31. Letellier T., Heinrich R., Malgat M., and Mazat J.P. The kinetic basis of threshold effects observed in mitochondrial diseases: a systemic approach. Biochem. J. 302 (1994) 171-174
32. Malgat M., Letellier T., Jouvaille S.L., and Mazat J.P. J. Biol. Syst. 3 (1995) 165-175
33. 2 production and bioenergetics in rat brain synaptosomes, BBA Bioenergetics EBEC Special Edition (In Press).
34. Perry T.L., Godin D.V., and Hansen S. Parkinson's disease: a disorder due to nigral glutathione deficiency?. Neurosci. Lett. 33 (1982) 305-310
35. Perry T.L., and Yong V.W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67 (1986) 269-274
36. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., and Youdim M.B.H. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52 (1989) 515-520
37. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
38. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Ther. 51 (1991) 155-194
39. Jain A., Martensson J., Stole E., Auld P.A.M., and Meister A. Glutathione deficiency leads to mitochondrial damage in brain. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 1913-1917
40. Heales S.J.R., Davies S.E.C., Bates T.E., and Clark J.B. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem. Res. 20 (1995) 31-38
41. Bolaños J.P., Heales S.J., Peuchen S., Barker J.E., Land J.M., and Clark J.B. Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21 (1996) 995-1001
42. Vásquez O.L., Almeida A., and Bolaños J.P. Depletion of glutathione up-regulates mitochondrial complex I expression in glial cells. J. Neurochem. 76 (2001) 1593-1596
43. Muyderman H., Nilsson M., and Sims N.R. Highly selective and prolonged depletion of mitochondrial glutathione in astrocytes markedly increases sensitivity to peroxynitrite. J. Neurosci. 24 (2004) 8019-8028
44. Mary-Semper I., Gelman M., and Levi-Strauss M. The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra. Eur. J. Neurosci. 5 (1993) 1029-1034
45. Mary-Semper I., Gelman M., and Levi-Strauss M. A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation. J. Neurosci. 15 (1995) 5912-5918
46. Sriram K., Shankar S.K., Boyd M.R., and Ravindranath V. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration. J. Neurosci. 18 (1998) 10287-10296
47. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., Liu R.M., Forman H.J., and Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 275 (2000) 26096-26101
48. Taylor E.R., Hurrell F., Shannon R.J., Lin T.K., Hirst J., and Murphy M.P. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 278 (2003) 19603-19610
49. Carroll J., Fearnley I.M., Skehel M., Shannon R.J., Hirst J., and Walker J.E. Bovine complex I is a complex of 45 different subunits. J. Biol. Chem. 281 (2006) 32724-32727
50. Chomyn A., Mariottini P., Cleeter M.W.J., Ragan C.I., Matsuno-Yagi A., Hatefi Y., Doolite R.F., and Attardi G. Six unidentified reading frames of human mitochondrial DNA encode components of the respiratory chain NADH-dehydrogenase. Nature 314 (1985) 592-597
51. Chomyn A., Cleeter M.W.J., Ragan C.I., Riley M., Doolite R.F., and Attardi G. URF6, last unidentified reading frame of human mtDNA codes for an NADH dehydrogenase subunit. Science 234 (1986) 614-618
52. Carroll J., Shannon R.J., Fearnley I.M., Walker J.E., and Hirst J. Definition of the nuclear encoded protein composition of bovine heart mitochondrial complex I. Identification of two new subunits. J. Biol. Chem. 277 (2002) 50311-50317
53. Hoogenraad N.J., Ward L.A., and Ryan M.T. Import and assembly of proteins into mitochondria of mammalian cells. Biochim. Biophys. Acta 1592 (2002) 97-105
54. Hofhaus G., Weiss H., and Leonard K. Electron microscopic analysis of the peripheral and membrane parts of mitochondrial NADH dehydrogenase (complex I). J. Mol. Biol. 221 (1991) 1027-1043
55. Guenebaut V., Vincentelli R., Mills D., Weiss H., and Leonard K.R. Three dimensional structure of NADH-dehydrogenase from Neurospora crassa by electron microscopy and conical tilt reconstruction. J. Mol. Biol. 265 (1997) 409-418
56. Leif H., Weidner U., Berger A., Spehr V., Braun M., van Heek P., Friedrich T., Ohnishi T., and Weiss H. Escherichia coli NADH dehydrogenase I, a minimal form of the mitochondrial complex I. Biochem. Soc. Trans. 21 (1993) 998-1001
57. Fearnley I.M., Carroll J., Shannon R.J., Runswick M.J., Walker J.E., and Hirst J. GRIM-19, a cell death regulatory gene product, is a subunit of bovine mitochondrial NADH:ubiquinone oxidoreductase (complex I). J. Biol. Chem. 276 (2001) 38345-38348
58. Ricci J.E., Munoz-Pinedo C., Fitzgerald P., Bailly-Maitre B., Perkins G.A., Yadava N., Scheffler I.E., Ellisman M.H., and Green D.R. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the P75 subunit of complex I of the electron transport chain. Cell 117 (2004) 773-786
59. Friedrich T., and Weiss H. Modular evolution of the respiratory NADH:ubiquinone oxidoreductase and the origin of its modules. J. Theor. Biol. 187 (1997) 529-540
60. Ugalde C., Vogel R., Huijbens R., van der Heuvel L.P., Smeitlink J., and Nijtmans L. Human mitochondrial complex I assembles through the combination of evolutionary conserved modules: a framework to interpret complex I deficiencies. Hum. Mol. Genet. 13 (2004) 2461-2472
61. Friedrich T., and Bottcher B. The gross structure of the respiratory complex I: a Lego system. Biochim. Biophys. Acta 1608 (2004) 1-9
62. Lazarou M., McKenzie M., Ohtake A., Thorburn D.R., and Ryan M.T. Analysis of the assembly profiles for mitochondrial and nuclear encoded subunits into complex I. Mol. Cell. Biol. 27 (2007) 4228-4237
63. Vogel R.O., Smeitink J., and Nijtmans L. Human mitochondrial complex I assembly: a dynamic and versatile process. Biochim. Biophys. Acta 1767 (2007) 1215-1227
64. Lazarou M., McKenzie M., Ohtake A., Thorburn D.R., and Ryan M.T. Analysis of the assembly profiles for mitochondrial and nuclear encoded subunits into complex I. Mol. Cell. Biol. 27 (2007) 4228-4237
65. Vogel R.O., van den Brand M.A., Rodenburg R.J., van den Heuvel L.P., Tsuneoka M., Smeitink J.A., and Nijtmans L.G. Investigation of the complex I assembly chaperones B17.2L and NDUFAF1 in a cohort of CI deficient patients. Mol. Genet. Metab. 91 (2007) 176-182
66. Vogel R.O., Janssen R.J., van den Brand M.A., Deinteren C.E., Verkaart S., Koopman W.J., Willems P.H., Pluk W., van den Heuvel L.P., Smeitink J.A., and Nijtmans L.G. Cytosolic signaling protein Ecsit also localizes to the mitochondria where it interacts with chaperone NDUFAF1 and functions in complex I assembly. Genes Dev. 21 (2007) 615-624
67. Ladha J.S., Tripathy M.K., and Mitra D. Mitochondrial complex I activity is impaired during HIV-1 induced T-cell apoptosis. Cell Death Diff. 12 (2005) 1417-1428
68. Hackenbrock C.R., Chazotte B., and Gupte S.S. The random collision model and a critical assessment of diffusion and collision in mitochondrial electron transport. J. Bioenerg. Biomembr. 18 (1986) 331-368
69. Lenaz G., Fato R., Genova M.L., Bergamini C., Bianchi C., and Biondi A. Mitochondrial complex I: structural and functional aspects. Biochim. Biophys. Acta 1757 (2006) 1406-1420
70. Schagger H., and Pfeiffer K. Supercomplexes in the respiratory chains of yeast and mammalian mitochondria. EMBO J. 19 (2000) 1777-1783
71. Wittig I., Carrozzo R., Santorelli F.M., and Schagger H. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 1757 (2006) 1066-1072
72. Bianchi C., Genova M.L., Castelli G., and Lenaz G. The mitochondrial respiratory chain is partially organized in a supercomplex assembly: kinetic evidence using flux control analysis. J. Biol. Chem. 279 (2004) 36562-36569
73. Schagger H., de Coo R., Bauer M.F., Hofmann S., Godinot C., and Brandt U. Significance of respirasomes for the assembly/stability of human respiratory chain complex I. J. Biol. Chem. 279 (2004) 36349-36353
74. Acin-Perez R., Bayona-Bafaluy M.P., Fernandez-Silva P., Moreno-Loshuertos R., Perez-Martos A., Bruno C., Moraes C.T., and Enriquez J.A. Respiratory complex III is required to maintain complex I in mammalian mitochondria. Mol. Cell 13 (2004) 805-815
75. Schagger H., and Pfeiffer K. The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J. Biol. Chem. 276 (2001) 37861-37867
76. Dudkina N.V., Eubel H., Keegstra W., Boekema E.J., and Braun H.P. Structure of a mitochondrial supercomplex formed by respiratory-chain complexes I and III. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3225-3229
77. Schafer E., Seelert H., Reifschneider N.H., Krause F., Dencher N.A., and Vonck J. Architecture of active mammalian respiratory chain supercomplexes. J. Biol. Chem. 281 (2006) 15370-15375
78. Fleischer S., Brierley G., Klouwen H., and Slautterback D.B. Studies of the electron transfer system. 47. The role of phospholipids in electron transfer. J. Biol. Chem. 237 (1962) 3264-3272
79. Fry M., and Green D.E. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. J. Biol. Chem. 256 (1981) 1874-1880
80. Vik B., and Capaldi R.A. Lipid requirements for cytochrome c oxidase activity. Biochemistry 19 (1977) 5755-5759
81. Pfeiffer K., Gohil V., Stuart R.A., Hunte C., Brandt U., Greenberg M.L., and Schagger H. Cardiolipin stabilizes respiratory chain supercomplexes. J. Biol. Chem. 278 (2003) 52873-52880
82. Paradies G., Petrosillo G., Pistolese M., and Ruggiero F.M. The effect of reactive oxygen species generated from mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles. FEBS Lett. 466 (2000) 323-326
83. Petrosillo G., Ruggiero F.M., Di Venosa N., and Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J. 17 (2003) 714-716
84. McKenzie M., Lazarou M., Thoburn D.R., and Ryan M.T. Mitochondrial respiratory chain supercomplexes are destabilized in Barth syndrome patients. J. Mol. Biol. 361 (2006) 462-469